Structure-Based Design of Novel Anticancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|1|1|59-71

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.1, Iss.1, 2001-05, pp. : 59-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Structure-Based and Ligand-Based Design of IKK&bgr; Inhibitors as Anti-inflammation and Anti-cancer Agents

By  

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-11 ,pp. : 3893-3917

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Drug Design, Molecular Dynamics and ADME/Tox to Investigate Protein Kinase Anti-Cancer Agents

By  

Current Bioactive Compounds, Vol. 13, Iss. 3, 2017-07 ,pp. : 213-222

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Design, Synthesis and Molecular Modeling Studies of Thiazolyl Urea Derivatives as Novel Anti-Parkinsonian Agents

By  

Medicinal Chemistry, Vol. 8, Iss. 6, 2012-11 ,pp. : 1057-1068

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based design of nitrosoureas containing tyrosine derivatives as potential antimelanoma agents

By Gadjeva V.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 4, 2002-04 ,pp. : 295-300

Elsevier

Access to resources Recommend Favorite

New Opportunities in the Structure-based Design of Anti-Protozoan Agents

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 1, 2017-01 ,pp. : 79-90

Bentham Science Publishers

Access to resources Recommend Favorite